Contact Us
Click here to contact Felicity Thomas,editor.
December 4, 2013
Dry AMD treatment Encouraging results for dry AMD treatment revealed Roche has announced additional encouraging results of a phase II study with lampalizumab to treat patients with geographic atrophy (GA). The MAHALO study data was presented during the Retina subspeciality day at AAO 2013 in New Orleans, Louisiana, USA. More...
Anti-VEGFs better than laser Anti-VEGFs superior to laser photocoagulation According to recently published data, anti-VEGF therapy is superior to laser photocoagulation for the treatment of moderate-to-severe visual impairment caused by diabetic macular oedema (DME). More...
Home monitoring benefits High-risk patients benefit from home monitoring The Home Monitoring of the Eye (HOME) study, conducted in AREDS2 clinical centres, has demonstrated that patients at high-risk of developing choroidal neovascularization (CNV) — the neovascular or wet phase of AMD — benefit from using the ForeseeHome monitoring device (Notal Vision). More...
Choosing and using the AcrySof IQ ReSTOR IOL family
Customized options for individual patients.
Read more:
The Safety of anti-VEGF Therapy Under the microscope, in trials and in clinical practice. Read more:
